| Date Filed | Type | Description |
| 10/03/2023 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on CENTENE CORP|
Txns:
| Granted 545 shares
@ $0 |
|
| 07/05/2023 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on CENTENE CORP|
Txns:
| Granted 544 shares
@ $0 |
|
| 05/12/2023 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on CENTENE CORP|
Txns:
| Granted 2,947 shares
@ $0 |
|
| 04/04/2023 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on CENTENE CORP|
Txns:
| Granted 511 shares
@ $0 |
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on CENTENE CORP|
Txns:
| Granted 406 shares
@ $0 |
|
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on CENTENE CORP|
Txns:
| Granted 2,323 shares
@ $0 |
|
| 04/04/2022 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on CENTENE CORP|
Txns:
| Granted 442 shares
@ $82.02, valued at
$36.2k
|
|
| 02/09/2022 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on CENTENE CORP|
Txns:
| Granted 1,100 shares
@ $0
Granted 10,000 options to buy
@ $80.57, valued at
$805.7k
|
|
| 01/14/2022 |
3
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 3 on CENTENE CORP |
| 08/05/2021 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on Prestige Consumer Healthcare Inc.|
Txns:
| Granted 2,808 shares
@ $0 |
|
| 07/23/2021 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 42,347 shares
@ $0
Disposed/sold 2,294 options to buy
@ $138.86, valued at
$318.5k
Disposed/sold 2,706 options to buy
@ $167.97, valued at
$454.5k
Disposed/sold 2,343 options to buy
@ $155.01, valued at
$363.2k
|
|
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2020 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Granted 3,468 shares
@ $0
Granted 2,774 shares
@ $0 |
|
| 05/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2020 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $86.65, valued at
$2.2M
|
|
| 04/28/2020 |
3
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 3 on Karuna Therapeutics, Inc. |
| 02/13/2020 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 08/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/17/2019 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS, INC.|
Txns:
| Granted 2,726 shares
@ $0
Granted 2,181 shares
@ $0 |
|
| 05/02/2019 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on Allergan plc|
Txns:
| Paid exercise price by delivering 953 shares
@ $147, valued at
$140.1k
Granted 2,064 shares
@ $145.33, valued at
$300k
|
|
| 03/21/2019 |
4/A
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on Allergan plc |
| 09/07/2018 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on Allergan plc|
Txns:
| Bought 1,300 shares
@ $190.55, valued at
$247.7k
Bought 705 shares
@ $190.56, valued at
$134.3k
Bought 27 shares
@ $190.57, valued at
$5.1k
Bought 100 shares
@ $190.58, valued at
$19.1k
Bought 356 shares
@ $190.59, valued at
$67.9k
Bought 400 shares
@ $190.6, valued at
$76.2k
Bought 200 shares
@ $190.61, valued at
$38.1k
Bought 68 shares
@ $190.62, valued at
$13k
Bought 100 shares
@ $190.65, valued at
$19.1k
Bought 816 shares
@ $190.66, valued at
$155.6k
Bought 222 shares
@ $190.67, valued at
$42.3k
|
|
| 05/11/2018 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 2,174 shares
@ $0 |
|
| 05/04/2018 |
4
| COUGHLIN CHRISTOPHER J (Director) has filed a Form 4 on Allergan plc|
Txns:
| Gifted 10,000 shares
@ $0
Granted 1,985 shares
@ $151.07, valued at
$299.9k
|
|
|